Congratulations to three AlbionVC portfolio companies for being named as London's best startups to work for in 2021: each company has its own stand-out superpower and should be on every candidate’s watchlist.
We are delighted to announce that AlbionVC portfolio company Aridhia together with its coalition partners today are launching Alzheimer’s Disease Data Initiative (ADDI) and Alzheimer’s disease (AD) Workbench, a cloud-based platform for scientists to accelerate discoveries and innovations for AD and related dementias.
Emil Gigov, Partner at AlbionVC reflects on the journey of Clear Review, a HR cloud solution that we had the pleasure of working with from Series A to their subsequent acquisition by Advanced.
Elliptic, Quantexa and Speechmatics named among the 25 fastest growing technology businesses in the UK.
Odin Vision, a UCL Technology Fund portfolio company has received a grant to accelerate its cutting edge AI technology to fight bowel cancer. Odin Vision’s technology assists doctors to detect and characterise cancerous and pre-cancerous polyps during colonoscopy procedures.
Pando, a messaging startup for doctors strikes a deal with the British Army to give thousands of troops deployed overseas access to medical expertise. Army medics have already sent more than 120,000 messages through the Pando app.
Freeline Therapeutics, a company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases, announced the pricing of its initial public offering in the United States. Freeline Nasdaq IPO is UCL Technology Fund's 3rd IPO since its inception in 2016.